JP2002306123A - Functional food - Google Patents

Functional food

Info

Publication number
JP2002306123A
JP2002306123A JP2001118470A JP2001118470A JP2002306123A JP 2002306123 A JP2002306123 A JP 2002306123A JP 2001118470 A JP2001118470 A JP 2001118470A JP 2001118470 A JP2001118470 A JP 2001118470A JP 2002306123 A JP2002306123 A JP 2002306123A
Authority
JP
Japan
Prior art keywords
communis
extract
water
functional food
dmdp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001118470A
Other languages
Japanese (ja)
Other versions
JP3581670B2 (en
Inventor
Genjiro Kusano
源次郎 草野
Makio Shibano
真喜雄 芝野
Kazuo Takeuchi
一男 竹内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YAMADA YAKKEN KK
Spirulina Bio Lab Ltd
Original Assignee
YAMADA YAKKEN KK
Spirulina Bio Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YAMADA YAKKEN KK, Spirulina Bio Lab Ltd filed Critical YAMADA YAKKEN KK
Priority to JP2001118470A priority Critical patent/JP3581670B2/en
Publication of JP2002306123A publication Critical patent/JP2002306123A/en
Application granted granted Critical
Publication of JP3581670B2 publication Critical patent/JP3581670B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a functional food effective for controlling rise in concentration of blood sugar, having safety to the human body. SOLUTION: This functional food comprises at least one of Commelina communis and Commelina communis var. hortensis as a main component. α- Glucosidase activity can be inhibited by 1-deoxynojirimycin and 2,5- dihydroxymethyl 3,4-dihydroxypyrrolidine(DMDP) contained in Commelina communis and Commelina communis var. hortensis.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、糖尿病や肥満症な
どを予防するための機能性食品に関するものである。
TECHNICAL FIELD The present invention relates to a functional food for preventing diabetes, obesity and the like.

【0002】[0002]

【従来の技術】国内における糖尿病患者は急激に増加す
る傾向にあり、1997年の厚生省の実態調査によれ
ば、その患者数は690万人であり、また、糖尿病と健
康との境界線にあたる予備群を含めると、その数は13
70万人にもなる。これらの患者は、血糖や血清インス
リンなどの濃度が特に食後において上昇して異常値を示
す。従って、これら血糖や血清インスリンなどの濃度が
上昇しないように抑制しコントロールする方法として、
炭水化物の消化吸収阻害が考えられており、実際に、α
−グルコシダーゼ阻害薬(α−glucosidase阻害薬、α
−GI)が血糖の濃度の上昇を抑える血糖上昇抑制剤と
して用いられている。このようなα−GIは血糖上昇抑
制剤として用いられるほかに、膵臓B細胞の疲弊を防止
し、さらにはインスリン非依存型糖尿病(NIDDM)
の発症予防につながることが期待されているものであ
る。
2. Description of the Related Art The number of diabetic patients in Japan tends to increase rapidly. According to a survey conducted by the Ministry of Health and Welfare in 1997, the number of patients is 6.90 million. Including groups, the number is 13
It will be 700,000. These patients exhibit abnormal levels of elevated levels of blood glucose and serum insulin, especially after eating. Therefore, as a method of suppressing and controlling the concentration of these blood sugars and serum insulin so as not to increase,
Inhibition of digestion and absorption of carbohydrates is considered, and in fact, α
-Glucosidase inhibitors (α-glucosidase inhibitors, α
-GI) has been used as a blood sugar increase inhibitor for suppressing an increase in blood sugar concentration. Such α-GI is used not only as a blood glucose elevation inhibitor but also to prevent exhaustion of pancreatic B cells, and furthermore, insulin-independent diabetes (NIDDM)
It is expected to lead to the prevention of the onset of the disease.

【0003】[0003]

【発明が解決しようとする課題】そこで、糖尿病や肥満
症などを予防する目的で、日常的に手軽に摂取または飲
食することができるものが望まれていた。
Therefore, for the purpose of preventing diabetes, obesity and the like, there has been a demand for a food which can be easily taken or eaten and consumed on a daily basis.

【0004】本発明は、血糖の濃度の上昇を抑えるのに
有効で、しかも人体に対して安全である機能性食品を提
供することを目的とするものである。
[0004] It is an object of the present invention to provide a functional food which is effective for suppressing an increase in blood glucose concentration and is safe for the human body.

【0005】[0005]

【課題を解決するための手段】本発明の請求項1に係る
機能性食品は、ツユクサとオオボウシバナの少なくとも
一方を主成分として成ることを特徴とするものであり、
ツユクサとオオボウシバナに含まれている1-deoxynojir
imycin(1−デオキシノジリマイシンであって、以下、
DNJと略することがある)と2,5-dihydroxymethyl3,4
-dihydroxypyrrolidine(2,5−ジハイドロオキシメ
チル3,4−ジハイドロオキシピロリジンであって、以
下、DMDPと略することがある)によりα−グルコシ
ダーゼ(α−glucosidase)の活性を阻害することがで
きる。
Means for Solving the Problems A functional food according to claim 1 of the present invention is characterized by comprising at least one of communis and sagebrush as a main component,
1-deoxynojir contained in communis and communis
imycin (1-deoxynojirimycin, hereinafter,
DNJ) and 2,5-dihydroxymethyl3,4
α-glucosidase activity can be inhibited by -dihydroxypyrrolidine (2,5-dihydroxymethyl 3,4-dihydroxypyrrolidine, sometimes abbreviated as DMDP hereinafter) .

【0006】本発明の請求項2に係る機能性食品は、ツ
ユクサとオオボウシバナの少なくとも一方の粉砕物を主
成分として成ることを特徴とするものであり、ツユクサ
とオオボウシバナに含まれているDNJとDMDPによ
りα−グルコシダーゼの活性を阻害することができる。
A functional food according to a second aspect of the present invention is characterized in that at least one of communis and communis are used as a main component, and DNJ and DMDP contained in communis and communis are used. Can inhibit the activity of α-glucosidase.

【0007】本発明の請求項3に係る機能性食品は、ツ
ユクサとオオボウシバナの少なくとも一方からの抽出物
を主成分として成ることを特徴とするものであり、ツユ
クサとオオボウシバナの抽出物に含まれているDNJと
DMDPによりα−グルコシダーゼの活性を阻害するこ
とができる。
[0007] The functional food according to claim 3 of the present invention is characterized in that it comprises an extract from at least one of communis and communis as a main component, and is contained in the extract of communis and communis. Α-glucosidase activity can be inhibited by DNJ and DMDP.

【0008】[0008]

【発明の実施の形態】以下、本発明の実施の形態を説明
する。
Embodiments of the present invention will be described below.

【0009】本発明の機能性食品はツユクサ科(Commel
inaceae)の植物であるツユクサ(Commelina communi
s)とオオボウシバナ(C.communis var.hortensis)の
一方あるいは両方の植物体の全草(茎、葉、根などの各
種部位)をそのままあるいは乾燥した後、粉末に粉砕し
たものを主成分とするものである。また、本発明の機能
性食品はツユクサとオオボウシバナの植物体の各種部位
をそのままあるいは乾燥し、必要に応じて粉砕した後、
水や熱水及び/又はエチルアルコール等のアルコールな
どの溶媒で抽出したものを主成分とするものである。ツ
ユクサとオオボウシバナには主活性成分として下記の化
学式で示される1-deoxynojirimycin(DNJ)と2,5-di
hydroxymethyl3,4-dihydroxypyrrolidine(DMDP)
の二つの化合物が含まれている。
[0009] The functional food of the present invention is Commelinae (Commel
inaceae, a plant of communis (Commelina communi)
s) and one or both plants of C. communis var. hortensis (whole plant parts such as stems, leaves and roots) as they are or after drying and then pulverized to powder. Things. In addition, the functional food of the present invention, as it is or dried various parts of the plant of the spiderwort and Oleaceae, pulverized if necessary,
The main component is one extracted with a solvent such as water, hot water and / or an alcohol such as ethyl alcohol. 1-deoxynojirimycin (DNJ) represented by the following chemical formula and 2,5-di
hydroxymethyl3,4-dihydroxypyrrolidine (DMDP)
Are included.

【0010】[0010]

【化1】 Embedded image

【0011】そして、本発明の機能性食品はツユクサや
オオボウシバナの粉砕物あるいは抽出液に含まれている
上記二つの化合物により二糖類の分解酵素であるα−グ
ルコシダーゼの活性を阻害することができ、血糖の上昇
を抑えることができるものである。DNJとDMDPは
それぞれ単独でα−グルコシダーゼの活性を阻害するこ
とは知られているが、ツユクサとオオボウシバナ(及び
抽出液)はそれぞれDNJとDMDPの両方を約1:1
で同時に含むものであり、従って、DNJとDMDPの
相乗効果により高いα−グルコシダーゼの活性阻害効果
を得ることができるものである。しかも、DNJとDM
DPをそれぞれ別々の物質から得た場合、これらを併用
しようとすると混合する必要があるが、本発明ではこの
ような混合の手間が必要ないものである。
The functional food of the present invention can inhibit the activity of α-glucosidase, a disaccharide-degrading enzyme, by the above two compounds contained in the pulverized or extract of communis or communis. It can suppress the rise of blood sugar. It is known that DNJ and DMDP each independently inhibit the activity of α-glucosidase, but communis and Aspergillus niger (and extract) reduce both DNJ and DMDP by about 1: 1.
Therefore, a high α-glucosidase activity inhibitory effect can be obtained by the synergistic effect of DNJ and DMDP. Moreover, DNJ and DM
When DPs are obtained from different substances, they need to be mixed in order to use them in combination. In the present invention, such mixing time is not required.

【0012】本発明は上記のツユクサやオオボウシバナ
の粉砕物そのものあるいは抽出物そのものを機能性食品
とすることができる。また、本発明の機能性食品はツユ
クサやオオボウシバナの粉砕物や抽出物を既知の飲食品
類などの他の成分に添加して形成することができる。他
の成分としては、例えば、口腔用組成物(ガム、キャン
デーなど)やかまぼこ、ちくわなどの加工水産ねり製
品、ソーセージ、ハムなどの畜産製品、洋菓子類、和菓
子類、生めん、中華めん、ゆでめん、ソバなどのめん
類、ソース、醤油、タレ、砂糖、ハチミツ、粉末あめ、
水あめなどの調味料、カレー粉、からし粉、コショウ粉
などの香辛料、ジャム、マーマレード、チョコレートス
プレッド、漬物、そう菜、ふりかけや、各種野菜・果実
の缶詰・瓶詰など加工野菜・果実類、チーズ、バター、
ヨーグルトなど乳製品、みそ汁、スープ、果実ジュー
ス、野菜ジュース、乳清飲料、清涼飲料、酒類などの飲
料、茶葉、その他、健康食品など一般的な飲食品類への
使用を例示することができる。また、本発明の機能性食
品は既知の賦形材やカプセル材を用いて各種の内用・外
用製剤類(動物用に使用する製剤も含む)のように、ア
ンプル状、カプセル状、丸剤、錠剤状、粉末状、顆粒
状、固形状、液状、ゲル状或いは気泡性のように形成し
ても良い。尚、抽出物は抽出液に溶解された状態で用い
ても良いし、抽出液から溶媒を除去して得られる結晶体
の状態で用いても良い。また、ツユクサやオオボウシバ
ナの粉砕物や抽出物を既知の飲食品類に添加したり既知
の賦形材やカプセル材を用いる場合、ツユクサやオオボ
ウシバナの粉砕物や抽出物の使用量は任意であるが、6
0kgの成人において上記の二つの主活性成分の一回当
たりの摂取量の合計が1〜40mgとなるように機能性
食品に含有させるのが好ましく、これにより、本発明の
機能性食品よる血糖上昇抑制を効果的に得ることができ
るものである。
According to the present invention, the pulverized material or the extract of the above-mentioned communis or communis can be used as a functional food. In addition, the functional food of the present invention can be formed by adding a pulverized product or extract of communis or communis to other components such as known foods and drinks. As other ingredients, for example, oral compositions (gum, candy, etc.) and kamaboko, processed seafood products such as Chikuwa, sausage, livestock products such as ham, Western confectionery, Japanese confectionery, raw noodles, Chinese noodles, yuden noodles, Noodles such as buckwheat, sauce, soy sauce, sauce, sugar, honey, powdered candy,
Seasonings such as syrup, spices such as curry powder, mustard powder, pepper powder, jams, marmalade, chocolate spreads, pickles, soybeans, sprinkles, and processed vegetables and fruits such as canned and bottled vegetables and fruits, cheese ,butter,
Examples thereof include use in dairy products such as yogurt, miso soup, soup, fruit juice, vegetable juice, drinks such as whey drinks, soft drinks, alcoholic beverages, tea leaves, and other general foods and drinks such as health foods. In addition, the functional food of the present invention uses known excipients and capsules, and can be used in the form of ampoules, capsules, and pills, such as various internal and external preparations (including preparations used for animals). It may be formed into a tablet, a powder, a granule, a solid, a liquid, a gel, or a foam. The extract may be used in a state of being dissolved in the extract, or may be used in a state of a crystal obtained by removing the solvent from the extract. In addition, when using a known excipient or capsule material to add a crushed material or extract of communis or communis to known foods and drinks, the amount of use of the crushed product or extract of communis or communis is optional, 6
It is preferable that the functional food is contained in a functional food such that the total intake of the two main active ingredients per serving is 0 to 40 mg in an adult of 0 kg. The suppression can be obtained effectively.

【0013】オオボウシバナの抽出物は、溶媒を用いて
オオボウシバナの植物体の全草(茎、葉、根などの各種
部位)を直接抽出する方法で得ることができる。抽出に
用いる溶媒としては水やアルコールを用いることがで
き、アルコールとしてはメタノール、エタノール、プロ
パノール、ブタノール等を用いることができる。また、
これらの溶媒を任意の比率で混合した混合溶媒を用いる
こともできる。上記の溶媒の中でも、水、エタノール、
または水とエタノールの混合溶媒を用いるのが好まし
く、水とエタノールの混合溶媒を用いる場合は、その混
合比率を通常、アルコール濃度で5〜95%、好ましく
は70%にするのが最適である。溶媒はオオボウシバナ
1gに対して3〜200ミリリットル、好ましくは5〜
30ミリリットル配合して抽出を行うようにする。
The extract of Pleurotus serrata can be obtained by a method of directly extracting the whole plant (various parts such as stems, leaves, roots, etc.) of the Pleurotus oleracea plant using a solvent. Water or alcohol can be used as a solvent used for the extraction, and methanol, ethanol, propanol, butanol, or the like can be used as the alcohol. Also,
A mixed solvent obtained by mixing these solvents at an arbitrary ratio can also be used. Among the above solvents, water, ethanol,
Alternatively, a mixed solvent of water and ethanol is preferably used. When a mixed solvent of water and ethanol is used, the mixing ratio is usually optimally 5 to 95%, preferably 70% in alcohol concentration. The solvent is used in an amount of 3 to 200 ml, preferably 5 to 200 g per 1 g of scabionaceae.
30 milliliters are blended for extraction.

【0014】抽出に際しては、オオボウシバナを適当な
大きさ(10〜20mm)に細切に切断することが好ま
しい。抽出方法は、オオボウシバナの粉砕物と溶媒の混
合物を80〜90℃で3時間程度加熱し、この後、還流
法で抽出することが好ましいが、上記加熱後に静置によ
り抽出してもよい。次に、冷却後ろ過し、そのろ液を減
圧下で45℃以下の温度で完全に溶媒を留去し、乾燥エ
キスとして抽出物を得ることができる。
At the time of extraction, it is preferable to cut the Scutellaria scabana into small pieces of an appropriate size (10 to 20 mm). As for the extraction method, it is preferable to heat a mixture of ground squid and a solvent at 80 to 90 ° C. for about 3 hours, and then to perform extraction by a reflux method. Next, the mixture is cooled and filtered, and the filtrate is completely evaporated at a temperature of 45 ° C. or lower under reduced pressure to completely remove the solvent, whereby an extract can be obtained as a dry extract.

【0015】また、本発明の血糖上昇抑制剤はこの抽出
物を溶媒に溶解した状態のままで使用しても良いし、粗
画分として得られるものを使用しても良い。しかしなが
ら、上記のような抽出により得られる抽出物は上記の二
つの主活性成分の含量が少なく、血糖の上昇抑制に寄与
しない不純物も多い。そこで、上記の抽出により得られ
る抽出物から水溶性塩基性画分を分離精製して分画し、
この水溶性塩基性画分を本発明の血糖上昇抑制剤として
用いるのが好ましく、これにより、DNJとDMDPの
含有量(濃度)が高い血糖上昇抑制剤を調製することが
できる。水溶性塩基性画分を分画するにあたっては既知
の方法を採用することができ、例えば、陽イオン交換樹
脂を備えるクロマトグラフィーを用いておこなうことが
できる。
Further, as the blood sugar increase inhibitor of the present invention, this extract may be used as it is dissolved in a solvent, or may be used as a crude fraction. However, the extract obtained by the above-mentioned extraction has a low content of the above two main active ingredients, and has many impurities which do not contribute to suppression of an increase in blood glucose. Therefore, the water-soluble basic fraction is separated and purified from the extract obtained by the above extraction and fractionated,
It is preferable to use this water-soluble basic fraction as the blood sugar increase inhibitor of the present invention, whereby a blood sugar increase inhibitor having a high content (concentration) of DNJ and DMDP can be prepared. A known method can be used for fractionating the water-soluble basic fraction, for example, by using chromatography provided with a cation exchange resin.

【0016】ここで、ツユクサ及びオオボウシバナと他
のツユクサ科植物とのα−グルコシダーゼ阻害活性を比
較する。まず、ツユクサ科植物として、ツユクサ、オオ
ボウシバナ、イボクサ(Aneilema Keisak)、ムラサキ
オモト(Rhoeo discolor)、ヤブミョウガ(Polliajapo
nica)、オオムラサキツユクサ(Tradescantia virgini
ana)、シロフハカタカラクサ(T.viridis)、ノハカタ
カラクサ(トキワツユクサ)(T.flumiensis)、ブライ
ダルベル(Tripogandra multiflora)を用意した。
Here, the α-glucosidase inhibitory activities of communis and communis plants with other communis plants are compared. First of all, as communis of the family Cyperaceae, communis, amaryllidaceae, antelope (Aneilema Keisak), murasakiomoto (Rhoeo discolor), and japonica (Polliajapo)
nica), Tradescantia virgini (Tradescantia virgini)
ana), T. viridis, T. flumiensis, and bridal bell (Tripogandra multiflora).

【0017】次に、図1に示す手順に従ってサンプルを
調製した。すなわち、乾燥させた上記のツユクサ科植物
の全草を適当な大きさに切断し、切断したツユクサ科植
物の全草50g(乾燥重量)を水2リットルに入れて加
熱して1時間の熱水抽出を行い、抽出液を濾過して得
た。次に、抽出液を弱酸性陽イオン交換樹脂(Amberlit
e CG-50)を固相として用いたカラムクロマトグラフィ
ーで処理した。この時の抽出液の温度は室温、抽出液の
流速は40〜60ミリリットル/分でカラム中に流下さ
せた。次に、上記の弱酸性陽イオン交換樹脂を水で洗浄
した後、次に、弱酸性陽イオン交換樹脂に吸着した成分
を濃度2.8%のアンモニア水で溶出し、この溶出液を
濃縮して粗塩基性画分を得た。次に、粗塩基性画分を水
に溶解してサンプルとした。
Next, a sample was prepared according to the procedure shown in FIG. That is, the dried whole plant of the spiderwort is cut into an appropriate size, and 50 g (dry weight) of the cut whole spiderwort is put in 2 liters of water and heated for 1 hour in hot water. Extraction was performed, and the extract was obtained by filtration. Next, the extract was diluted with a weak acidic cation exchange resin (Amberlit).
e CG-50) was used as the solid phase for column chromatography. At this time, the temperature of the extract was lowered to room temperature, and the flow rate of the extract was lowered into the column at 40 to 60 ml / min. Next, after washing the weakly acidic cation exchange resin with water, the components adsorbed on the weakly acidic cation exchange resin are eluted with 2.8% ammonia water, and the eluate is concentrated. Thus, a crude basic fraction was obtained. Next, the crude basic fraction was dissolved in water to obtain a sample.

【0018】そして、上記の各ツユクサ科植物から得ら
れたサンプルのα−グルコシダーゼに対する阻害率をジ
ニトロサリチル酸(DNS)法により求めた。DNS法
は以下の[化2]に示すような反応を用いるものであ
る。
[0018] Then, the inhibitory rate against α-glucosidase of the samples obtained from each of the above-mentioned communis plants was determined by the dinitrosalicylic acid (DNS) method. The DNS method uses a reaction as shown in the following [Chemical formula 2].

【0019】[0019]

【化2】 Embedded image

【0020】DNS法は図2に示すようにして行う。す
なわち、まず、25マイクロリットルのサンプルに濃
度50mMでpH7.0のリン酸緩衝液(phosphate bu
ffer)を200マイクロリットル加えて37℃で5分間
加温した。次に、サンプルを混入した緩衝溶液に基質溶
液(濃度100mMのショ糖水溶液)を175マイクロ
リットル加えて37℃で5分間加温した。次に、この
溶液に酵素溶液(100マイクロリットルのα−グルコ
シダーゼ溶液)を加えて37℃で30分間反応した。
(尚、α−グルコシダーゼ溶液は酵素標準品(Saccharo
myces sp.由来)を濃度10mMでpH7.0のリン酸
緩衝液で1mg/ミリリットルに溶解し、同緩衝液で約
40倍に希釈したものを用いた。)次に、α−グルコ
シダーゼ溶液を加えた溶液にDNS溶液を加えて100
℃で10分間反応した。(尚、DNS溶液は水1リット
ルに対して、3,5-dinitrosalicylic acid(DNS)を1%、
酒石酸カリウムを5%、NaOHを1%、フェノールを
0.2%、Na2SO3を0.05%の割合で溶解した溶
液を用いた。)そして、DNS溶液を加えた溶液を水
で3倍に希釈した後、540nmにおける3−アミノ−
5−ニトロサリチル酸の光学濃度を測定(ODsample)
し、以下の式で阻害率を算出した。 阻害率(%)=100-(ODsample-ODblank)/(ODcontrol-ODblan
k)×100 ODcontrolはの操作でサンプルの代わりにH2Oで反応
を行ったときの光学濃度、ODblankはの操作で酵素溶
液の代わりに緩衝液を加えて行ったときの光学濃度をそ
れぞれ示す。
The DNS method is performed as shown in FIG. That is, first, a phosphate buffer (phosphate buffer) having a concentration of 50 mM and a pH of 7.0 was added to a 25 microliter sample.
ffer) and heated at 37 ° C. for 5 minutes. Next, 175 microliters of a substrate solution (100 mM sucrose aqueous solution) was added to the buffer solution mixed with the sample, and heated at 37 ° C. for 5 minutes. Next, an enzyme solution (100 microliters of α-glucosidase solution) was added to this solution and reacted at 37 ° C. for 30 minutes.
(Note that the α-glucosidase solution is an enzyme standard (Saccharo
myces sp.) was dissolved at a concentration of 10 mM in a phosphate buffer having a pH of 7.0 to 1 mg / ml and diluted about 40-fold with the same buffer. ) Next, the DNS solution was added to the solution to which the α-glucosidase solution had been added to prepare a solution.
The reaction was performed at 10 ° C. for 10 minutes. (Note that the DNS solution contains 1% of 3,5-dinitrosalicylic acid (DNS) per liter of water,
A solution in which 5% of potassium tartrate, 1% of NaOH, 0.2% of phenol, and 0.05% of Na 2 SO 3 were used was used. ) Then, the solution to which the DNS solution was added was diluted 3-fold with water, and then the 3-amino-
Measure optical density of 5-nitrosalicylic acid (ODsample)
Then, the inhibition rate was calculated by the following equation. Inhibition rate (%) = 100- (ODsample-ODblank) / (ODcontrol-ODblan
k) × 100 ODcontrol indicates the optical density when the reaction was performed with H 2 O instead of the sample in the operation, and ODblank indicates the optical density when the buffer was added instead of the enzyme solution in the operation. .

【0021】上記の各ツユクサ科植物の阻害率を表1に
示す。
Table 1 shows the inhibition rates of the above-mentioned communis plants.

【0022】[0022]

【表1】 [Table 1]

【0023】表1から明らかなように、ツユクサやオオ
ボウシバナから得られる熱水抽出物の水溶性塩基性画分
は他のツユクサ科植物から得られる熱水抽出物の水溶性
塩基性画分よりも阻害率が高く、従って、本発明ではツ
ユクサ科植物の中でもツユクサやオオボウシバナを用い
るのである。
As is evident from Table 1, the water-soluble basic fraction of the hot water extract obtained from the spiderwort or St. John's wort is higher than the water-soluble basic fraction of the hot water extract obtained from other communis plants. The inhibitory rate is high, and thus, in the present invention, communis plants and St. John's wort are used among the communis plants.

【0024】また、オオボウシバナから得られる熱水抽
出物の水溶性塩基性画分の成分の同定を行った。まず、
図3に示す方法で成分1、2を得た。すなわち、乾燥さ
せたオオボウシバナの全草を適当な大きさに切断し、切
断したオオボウシバナの全草1.2kg(乾燥重量)を
水40リットルに入れて加熱して1時間の熱水抽出を行
い、抽出液を濾過して得た。次に、抽出液を弱酸性陽イ
オン交換樹脂(Amberlite CG-50)を固相として用いた
カラムクロマトグラフィーで処理した。この時の抽出液
の温度は室温、抽出液の流速は40〜60ミリリットル
/分でカラム中に流下させた。次に、上記の弱酸性陽イ
オン交換樹脂に吸着した成分を濃度2.8%のアンモニ
ア水で溶出し、この溶出液の溶媒を除去することによっ
て粗塩基性画分を得た。次に、粗塩基性画分を水に溶解
し、この粗塩基性画分溶液を0.2MでpH5.7のギ
酸アンモニウム緩衝液で緩衝化させた強酸性陽イオン交
換樹脂(DOWEX 50WX4)を固相として用いたカラムクロ
マトグラフィーで処理した。この時、粗塩基性画分溶液
の温度は室温、粗塩基性画分溶液の流速は10ミリリッ
トル/分でカラム中に流下させた。
In addition, the components of the water-soluble basic fraction of the hot water extract obtained from Streptomyces chinensis were identified. First,
Components 1 and 2 were obtained by the method shown in FIG. That is, the dried whole plant of Oboushibana was cut into an appropriate size, and 1.2 kg (dry weight) of cut whole plant of Oboushibana was put into 40 liters of water, heated and subjected to hot water extraction for 1 hour, The extract was obtained by filtration. Next, the extract was subjected to column chromatography using a weakly acidic cation exchange resin (Amberlite CG-50) as a solid phase. At this time, the temperature of the extract was lowered to room temperature, and the flow rate of the extract was allowed to flow down the column at 40 to 60 ml / min. Next, the component adsorbed on the weakly acidic cation exchange resin was eluted with 2.8% ammonia water, and the solvent in the eluate was removed to obtain a crude basic fraction. Next, the crude basic fraction was dissolved in water, and a strongly acidic cation exchange resin (DOWEX 50WX4) obtained by buffering the crude basic fraction solution with an ammonium formate buffer having a pH of 5.7 at 0.2 M was used. It was processed by column chromatography used as the solid phase. At this time, the temperature of the crude basic fraction solution was set to room temperature, and the flow rate of the crude basic fraction solution was allowed to flow down the column at 10 ml / min.

【0025】次に、上記の強酸性陽イオン交換樹脂に吸
着した成分を0.28%アンモニア水(1→100)で
溶出し、溶出液の溶媒を除去することによって、0.2
8%アンモニア水溶出画分を得た。そして、上記の0.
28%アンモニア水溶出画分を高速液体クロマトグラフ
ィー(HPLC,Asahipak NH2P,80%
CH3CN)で処理して成分1と成分2を得た。この成
分1と成分2を核磁気共鳴分光法(1H−NMRspe
ctrum(D2O))で解析した。結果を図4、図5
に示す。
Next, the components adsorbed on the strongly acidic cation exchange resin are eluted with 0.28% aqueous ammonia (1 → 100), and the solvent of the eluate is removed to obtain a 0.2% aqueous solution.
An 8% aqueous ammonia elution fraction was obtained. Then, the above 0.
The fraction eluted with 28% aqueous ammonia was subjected to high performance liquid chromatography (HPLC, Asahipak NH 2 P, 80%
CH 3 CN) to give Component 1 and Component 2. Component 1 and component 2 were combined with nuclear magnetic resonance spectroscopy ( 1 H-NMR spe
ctrum (D 2 O)). 4 and 5 show the results.
Shown in

【0026】成分1は図4のような1H−NMRスペク
トルを示し、各シグナルは化学シフトの値、カップリン
グ定数、1H−1HCOSYスペクトル、1H−13CCO
SYスペクトルの解析結果を統合して、低磁場側から3
位と4位の水素(2H相当)、ヒドロキシメチル基の水
素(4H相当)、2位と5位の水素(2H相当)に帰属
することができた。
Component 1 shows a 1 H-NMR spectrum as shown in FIG. 4, and each signal is a chemical shift value, a coupling constant, a 1 H- 1 HCOSY spectrum, and a 1 H- 13 CCO spectrum.
By integrating the analysis results of the SY spectrum, 3
It could be attributed to hydrogen at the 4-position and 4-position (corresponding to 2H), hydrogen of the hydroxymethyl group (corresponding to 4H), and hydrogen at the 2-position and 5-position (corresponding to 2H).

【0027】成分2は図5のような1H−NMRスペク
トルを示し、成分1と類似の解析結果を統合して、各シ
グナルを図に示したように帰属することができた。
Component 2 showed a 1 H-NMR spectrum as shown in FIG. 5, and the analysis results similar to those of Component 1 were integrated, and each signal could be assigned as shown in the figure.

【0028】成分1はDMDPであり、色のない粉体で
あった。また、次のような性質を示すものであった。 ニンヒドリン反応:positive(orange) SI−MS(質量スペクトル):m/z164(M+
1)であり、分子量が163で分子式がC613NO4
あることを意味する。[α]D+74.0°(c=0.
07,H2O)であり、この値は天然由来のDMDP固
有の値であって、合成DMDPではないことを示してい
る。
Component 1 was DMDP, a colorless powder. In addition, it exhibited the following properties. Ninhydrin reaction: positive (orange) SI-MS (mass spectrum): m / z 164 (M +
1), which means that the molecular weight is 163 and the molecular formula is C 6 H 13 NO 4 . [Α] D + 74.0 ° (c = 0.
07, H 2 O), indicating that this value is unique to naturally occurring DMDP and not synthetic DMDP.

【0029】また、成分2はDNJであり、色のない粉
体であった。また、次のような性質を示すものであっ
た。 ニンヒドリン反応:positive(yellow) SI−MS(質量スペクトル):m/z164(M+
1)であり、分子量が163で分子式がC613NO4
あることを意味する。[α]D−30.5°(c=0.
10,H2O)であり、この値は天然由来のDNJ固有
の値であって、合成DNJではないことを示している。
Component 2 was DNJ, which was a colorless powder. In addition, it exhibited the following properties. Ninhydrin reaction: positive (yellow) SI-MS (mass spectrum): m / z 164 (M +
1), which means that the molecular weight is 163 and the molecular formula is C 6 H 13 NO 4 . [Α] D -30.5 ° (c = 0.
10, H 2 O), indicating that this value is unique to a naturally occurring DNJ and not a synthetic DNJ.

【0030】また、オオボウシバナから得られる熱水抽
出物の水溶性塩基性画分中のDNJとDMDPの定量を
行った。まず、図6に示す方法でHPLC用サンプルを
得た。すなわち、恒量にしたオオボウシバナの粉末50
0mgを精秤し、50%CH 3CNを10ミリリットル
正確に加え、20分間超音波抽出した。次に、以下の分
析の前処理として、HPLCのカラムの保護のため、同
じ中身の樹脂に一度通して共稚物を取り除いた(Sep
pakNH2(Waters))。次に、ゴミなどによ
り配管等を詰まらせないために、ろ過(0.22μm)
を行った。このようにして高速液体クロマトグラフィー
用のサンプルを調製した。このサンプルを用いて高速液
体クロマトグラフィー/質量分析(LC/MS)を行っ
た。LC/MS条件は次の通りである。 カラム:Asahipak NH2P,4.6mmi.
d×250mm 移動相:75%CH3CN 流速:0.8ミリリットル/min カラム温度:25℃ 注入量:5マイクロリットル(カット注入) 検出:イオントラップ型質量分析計 イオン化:大気圧化学イオン化法(APCI) 極性:ポジティブ 噴霧器温度:180℃ 脱溶媒室温度:350℃ 第一細孔温度:120℃ 第二細孔温度:120℃ ニードル電圧:3.00kV ドリフト電圧:100V フォーカス電圧:30V 上記のLC/MS分析の結果を図7にグラフで示す。
尚、グラフ中のオオボウシバナ1は草津市内で栽培した
もの、オオボウシバナ2は大阪薬科大学の薬用植物園で
栽培したもの、オオボウシバナ3はオオボウシバナ1の
根部である。ツユクサ科植物のツユクサの結果も併記す
る。
In addition, the hot water extraction obtained from A.
Determination of DNJ and DMDP in the water-soluble basic fraction of the product
went. First, an HPLC sample was prepared by the method shown in FIG.
Obtained. In other words, the powdered powder of Trichophyton serrata 50
0 mg is weighed accurately and 50% CH Three10 ml of CN
Accurately added and sonicated for 20 minutes. Next,
As a pretreatment for the analysis, to protect the HPLC column,
Once through the resin in the same contents to remove the co-birth products (Sep
pakNHTwo(Waters)). Next, use garbage
Filtration (0.22μm) to prevent clogging of piping
Was done. In this way, high performance liquid chromatography
Sample was prepared. High-speed liquid using this sample
Chromatography / mass spectrometry (LC / MS)
Was. The LC / MS conditions are as follows. Column: Asahipak NHTwoP, 4.6 mmi.
d × 250 mm Mobile phase: 75% CHThreeCN flow rate: 0.8 ml / min Column temperature: 25 ° C. Injection volume: 5 microliters (cut injection) Detection: ion trap mass spectrometer Ionization: Atmospheric pressure chemical ionization (APCI) Polarity: positive Sprayer temperature: 180 ° C. Desolvation chamber temperature: 350 ° C First pore temperature: 120 ° C Second pore temperature: 120 ° C Needle voltage: 3.00 kV Drift voltage: 100 V Focus voltage: 30 V The results of the above LC / MS analysis are graphed in FIG. Indicated by
In addition, the Obanoshibana 1 in the graph was grown in Kusatsu City.
Stuffed squirrel, 2 at Osaka Pharmaceutical University Medicinal Botanical Garden
What was cultivated.
It is the root. The results for the communis of the communis are also included.
You.

【0031】図7から明らかなように、ツユクサ及びオ
オボウシバナには約0.02〜0.06%のDMDPと
DNJが含有されている。
As is apparent from FIG. 7, the spiderwort and Oleaceae contain about 0.02-0.06% of DMDP and DNJ.

【0032】また、図8に示すように、上記のオオボウ
シバナの場合と同様にしてツユクサから得られる成分
1、2を得て、ツユクサから得られる熱水抽出物の水溶
性塩基性画分の成分の同定を行った。そして、オオボウ
シバナの場合と同様にして成分1と成分2を核磁気共鳴
分析法(1H−NMRspectrum(D2O))で分
析した。結果を図9に示す。上記のオオボウシバナの場
合と同様に、成分1はDMDP、成分2はDNJであ
り、それぞれオオボウシバナの場合と同様の性質を示し
た。
As shown in FIG. 8, the components 1 and 2 obtained from the spiderwort are obtained in the same manner as in the case of Streptomyces banana, and the components of the water-soluble basic fraction of the hot water extract obtained from the spiderwort are obtained. Was identified. And analyzed by the same procedure as that in Ooboushibana components 1 and 2 nuclear magnetic resonance spectroscopy (1 H-NMRspectrum (D 2 O)). FIG. 9 shows the results. In the same manner as in the above-mentioned case, component 1 was DMDP, and component 2 was DNJ.

【0033】また、図10に示すように、上記のオオボ
ウシバナの場合と同様にしてツユクサから得られる熱水
抽出物のHPLC用サンプルの作成し、ツユクサから得
られる熱水抽出物の水溶性塩基性画分中のDNJとDM
DPの定量を行った。LC/MS条件は上記のオオボウ
シバナの場合と同様である。
As shown in FIG. 10, a sample for HPLC of the hot water extract obtained from the spiderwort was prepared in the same manner as in the case of St. John's wort, and the water-soluble basic DNJ and DM in fractions
DP was quantified. The LC / MS conditions are the same as in the case of Streptomyces japonica.

【0034】上記のLC/MSによる定量分析の結果を
図11にグラフで示す。尚、グラフ中のツユクサ1、
2、3は野生品(高槻市周辺)で栽培したもの、ツユク
サ4は大阪薬科大の薬用植物園で栽培したもの、ツユク
サ5はツユクサ4において葉にふ模様のあるものであ
る。
FIG. 11 is a graph showing the results of the quantitative analysis by LC / MS. In addition, the communis 1 in the graph
2 and 3 are cultivated in wild products (around Takatsuki City), aspera 4 is cultivated in a medicinal botanical garden of Osaka Pharmaceutical University, and aspergillus 5 is leafy in the periwinkle 4.

【0035】図11から明らかなように、オオボウシバ
ナには約0.02〜0.12%のDMDPとDNJが含
有されている。
As is evident from FIG. 11, the scabion contains about 0.02-0.12% of DMDP and DNJ.

【0036】図12にDMDP及びDNJ標準溶液によ
る検量線をグラフで示す。標準溶液1はDMDPを75
ppmとDNJを75ppmそれぞれ含むものである。
また、標準溶液2はDMDPを150ppmとDNJを
150ppmそれぞれ含むものである。また、注入量は
5マイクロリットルとした。図12から明らかなよう
に、相関係数が0.997以上の良好な検量線が得られ
ている。
FIG. 12 is a graph showing a calibration curve using DMDP and DNJ standard solutions. Standard solution 1 contains 75 DMDP.
and 75 ppm of DNJ and DNJ, respectively.
The standard solution 2 contains 150 ppm of DMDP and 150 ppm of DNJ, respectively. The injection amount was 5 microliter. As is clear from FIG. 12, a good calibration curve with a correlation coefficient of 0.997 or more was obtained.

【0037】[0037]

【実施例】以下本発明を実施例によって具体的に説明す
る。
The present invention will be described below in detail with reference to examples.

【0038】(実施例1)乾燥したツユクサを適当な大
きさに切断粉砕して得られた粉砕物を機能性食品とし
た。
Example 1 A pulverized product obtained by cutting and pulverizing dried communis to an appropriate size was used as a functional food.

【0039】(実施例2)ツユクサの代わりに、乾燥し
たオオボウシバナを用いた以外は実施例1と同様にして
機能性食品を製造した。
(Example 2) A functional food was produced in the same manner as in Example 1 except that a dried bamboo was used in place of the spiderwort.

【0040】(実施例3)ツユクサの代わりに、乾燥し
たツユクサと乾燥したオオボウシバナを1:1で混合し
たものを用いた以外は実施例1と同様にして機能性食品
を製造した。
(Example 3) A functional food was produced in the same manner as in Example 1 except that a mixture of dried communis and dried banana were used in a ratio of 1: 1.

【0041】(実施例4)ツユクサを適当な大きさに切
断し、切断したツユクサ15g(乾燥重量)を水に入れ
て加熱して1時間の熱水抽出を行い、抽出液を濾過して
得た。次に、抽出残渣に1リットルの水を加え、上記と
同様の熱水抽出を行った。この後、さらに抽出残渣に1
リットルの水を加え、上記と同様の熱水抽出を行った。
そして、3回の熱水抽出で得た抽出液を合わせて機能性
食品を製造した。
Example 4 A spiderwort was cut into a suitable size, 15 g (dry weight) of the cut spiderwort was put in water, heated, subjected to hot water extraction for 1 hour, and filtered to obtain an extract. Was. Next, 1 liter of water was added to the extraction residue, and the same hot water extraction was performed as described above. After this, 1 residue was further added to the extraction residue.
One liter of water was added, and hot water extraction was performed as described above.
Then, a functional food was manufactured by combining the extracts obtained by the three hot water extractions.

【0042】(実施例5)ツユクサの代わりに、乾燥し
たオオボウシバナを用いた以外は実施例4と同様にして
機能性食品を製造した。
(Example 5) A functional food was produced in the same manner as in Example 4 except for using a dried bamboo banana in place of the spiderwort.

【0043】(実施例6)ツユクサの代わりに、乾燥し
たツユクサと乾燥したオオボウシバナを1:1で混合し
たものを用いた以外は実施例4と同様にして機能性食品
を製造した。
(Example 6) A functional food was produced in the same manner as in Example 4 except that a mixture of dried communis and a dried safflower in a ratio of 1: 1 were used instead of communis.

【0044】(実施例7)図13に示す方法で水溶性塩
基性画分を得た。ツユクサを適当な大きさに切断し、切
断したツユクサ15g(乾燥重量)を水に入れて加熱し
て1時間の熱水抽出を行い、抽出液を濾過して得た。次
に、抽出残渣に1リットルの水を加え、上記と同様の熱
水抽出を行った。この後、さらに抽出残渣に1リットル
の水を加え、上記と同様の熱水抽出を行った。
Example 7 A water-soluble basic fraction was obtained by the method shown in FIG. The spiderwort was cut into a suitable size, 15 g (dry weight) of the cut spiderwort was placed in water, heated and subjected to hot water extraction for 1 hour, and the extract was obtained by filtration. Next, 1 liter of water was added to the extraction residue, and the same hot water extraction was performed as described above. Thereafter, 1 liter of water was further added to the extraction residue, and the same hot water extraction was performed as described above.

【0045】次に、上記3回の熱水抽出で得た抽出液を
合わせ、弱酸性陽イオン交換樹脂(Amberlite CG-50)
を固相として用いたカラムクロマトグラフィーで処理し
た。この時の抽出液の温度は室温、抽出液の流速は40
〜60ミリリットル/分で、抽出液を3時間かけてカラ
ム中に流下させた。
Next, the extracts obtained by the above-mentioned three hot water extractions were combined, and weakly acidic cation exchange resin (Amberlite CG-50) was used.
Was subjected to column chromatography using as a solid phase. At this time, the temperature of the extract was room temperature, and the flow rate of the extract was 40.
At 60 ml / min, the extract was allowed to flow down the column over 3 hours.

【0046】次に、上記の弱酸性陽イオン交換樹脂に吸
着した成分を濃度2.8%のアンモニア水で溶出し、こ
の溶出液の溶媒を除去することによって110mgの粗
塩基性画分を得た。次に、粗塩基性画分を水に溶解し、
この粗塩基性画分溶液をpH5.7のギ酸アンモニウム
緩衝液で緩衝させた強酸性陽イオン交換樹脂(DOWEX50W
X4)を固相として用いたカラムクロマトグラフィーで処
理した。この時、粗塩基性画分溶液の温度は室温、粗塩
基性画分溶液の流速は10ミリリットル/分で、粗塩基
性画分溶液を3時間かけてカラム中に流下させた。
Next, the component adsorbed on the weakly acidic cation exchange resin was eluted with 2.8% ammonia water, and the solvent of this eluate was removed to obtain 110 mg of a crude basic fraction. Was. Next, the crude basic fraction was dissolved in water,
A strongly acidic cation exchange resin (DOWEX50W) obtained by buffering the crude basic fraction solution with an ammonium formate buffer having a pH of 5.7.
X4) was used as the solid phase for column chromatography. At this time, the temperature of the crude basic fraction solution was room temperature, the flow rate of the crude basic fraction solution was 10 ml / min, and the crude basic fraction solution was allowed to flow down the column over 3 hours.

【0047】次に、上記の強酸性陽イオン交換樹脂に吸
着した成分を水と濃度0.28%のアンモニア水と濃度
2.8%のアンモニア水で順次溶出し、各溶出液の溶媒
を除去することによって、70mgの水溶出画分と、2
0mgの0.28%アンモニア水溶出画分と、10mg
の2.8%アンモニア水溶出画分を得た。
Next, the components adsorbed on the strongly acidic cation exchange resin are sequentially eluted with water, aqueous ammonia having a concentration of 0.28% and aqueous ammonia having a concentration of 2.8%, and the solvent of each eluate is removed. By doing so, 70 mg of the water-eluted fraction
0 mg of the 0.28% aqueous ammonia eluted fraction and 10 mg
Of 2.8% ammonia water was obtained.

【0048】そして、上記の0.28%アンモニア水溶
出画分を機能性食品とした。
The fraction eluted with 0.28% aqueous ammonia was defined as a functional food.

【0049】(実施例8)ツユクサの代わりに、オオボ
ウシバナを用いた以外は実施例7と同様にして機能性食
品を製造した。
(Example 8) A functional food was produced in the same manner as in Example 7 except that St. John's wort was used in place of the spiderwort.

【0050】(実施例9)ツユクサの代わりに、ツユク
サとオオボウシバナを1:1で混合したものを用いた以
外は実施例7と同様にして機能性食品を製造した。
(Example 9) A functional food was produced in the same manner as in Example 7 except that a mixture of the spiderwort and St. John's wort (1: 1) was used instead of the spiderwort.

【0051】(比較例1)アルガボースを血糖上昇抑制
剤とした。
Comparative Example 1 Argabose was used as a blood glucose elevation inhibitor.

【0052】(比較例2)ボグリボースを血糖上昇抑制
剤とした。
Comparative Example 2 Voglibose was used as a blood glucose elevation inhibitor.

【0053】(阻害活性試験)実施例4〜9及び比較例
1、2について、α−グルコシダーゼの阻害活性試験を
図2に示す上記のDNS法に準じて行った。
(Inhibition Activity Test) The α-glucosidase inhibitory activity test of Examples 4 to 9 and Comparative Examples 1 and 2 was performed according to the above-mentioned DNS method shown in FIG.

【0054】α−グルコシダーゼの阻害活性試験の結果
をIC50値として表2に示す。
The results of the α-glucosidase inhibitory activity test are shown in Table 2 as IC 50 values.

【0055】[0055]

【表2】 [Table 2]

【0056】(血糖上昇抑制試験)実施例1〜9の血糖
上昇抑制試験としてスクロース負荷試験を以下のように
して行った。
(Test for Inhibition of Increase in Blood Sugar) As a test for inhibiting the increase in blood sugar in Examples 1 to 9, a sucrose load test was performed as follows.

【0057】動物はddYマウス♂7週令(一群5匹)
を用いた。負荷糖としてはsucrose(スクロース)を用
いた。
Animals are ddY mice @ 7 weeks old (5 animals per group)
Was used. Sucrose (sucrose) was used as a loading sugar.

【0058】そして、一晩絶食したマウス(一群5匹)
の空腹時血中グルコース濃度を測定した後、マウスに負
荷糖を4g/kg強制経口投与すると共に、負荷糖を投
与したマウスの一群に実施例1〜9をそれぞれ別々に強
制経口投与した。また、比較のために、負荷糖を投与し
たマウスのある一群にDNJを10mg/kg強制経口
投与し、別の一群にDMDPを10mg/kg強制経口
投与した。また、対照のために、負荷糖を投与したマウ
スのある一群に脱イオン水を20mg/kg強制経口投
与した。そして、実施例等を投与した後、30分後に尾
静脈から採血し、血中のグルコース濃度を測定して血糖
値とした。測定方法はキットによるグルコースオキシタ
ーゼ法(ロート製薬)である。スクロース負荷試験の結
果を図14に示す。尚、図14において、blankは
負荷糖や実施例等を与えなかったもの、control
は脱イオン水を与えたもの、normalは負荷糖のみ
を与えたものをそれぞれ示す。
Then, mice fasted overnight (5 mice per group)
After measuring the fasting blood glucose concentration of the mice, 4 g / kg of the loaded sugar was forcibly administered to the mice, and Examples 1 to 9 were separately orally administered to the group of mice to which the loaded sugar was administered. For comparison, one group of mice to which the sugar load was administered was gavaged with 10 mg / kg of DNJ and another group was gavaged with 10 mg / kg of DMDP. In addition, as a control, a group of mice to which the loaded sugar was administered was gavaged with 20 mg / kg of deionized water. After administration of the examples, blood was collected from the tail vein 30 minutes after administration, and the glucose concentration in the blood was measured to determine the blood glucose level. The measuring method is a glucose oxidase method using a kit (Rohto Pharmaceutical). FIG. 14 shows the results of the sucrose load test. In FIG. 14, blank is a sample in which no loaded sugar, no working example, etc. were given.
Indicates a case in which deionized water was provided, and normal indicates a case in which only the loaded sugar was provided.

【0059】尚、実施例1乃至6の投与量は200mg
/kgとし、実施例7乃至9の投与量は50mg/kg
とした。
The dose of Examples 1 to 6 was 200 mg.
/ Kg, and the dose of Examples 7 to 9 is 50 mg / kg.
And

【0060】本発明は材料の入手が容易で、自然環境保
全にも寄与する植物であること、及び図14から明らか
なように、実施例1〜9はDNJ単独及びDMDP単独
の約100分の1に相当する量で、それらに相当する血
糖低下作用を示すものであり、従って、食品材料等とし
て使用するのに安全性が高く、使用量を適量に制御し易
いものである。
The present invention is a plant whose material is easily available and contributes to the preservation of the natural environment. As is apparent from FIG. 14, Examples 1 to 9 show that the DNJ alone and the DMDP alone are about 100 minutes. An amount corresponding to 1 exhibits a blood glucose lowering effect corresponding thereto, and therefore, it is highly safe to use as a food material or the like, and it is easy to control the use amount to an appropriate amount.

【0061】[0061]

【発明の効果】上記のように本発明の請求項1の発明
は、ツユクサとオオボウシバナの少なくとも一方を主成
分として成ることを特徴とするものであり、ツユクサや
オオボウシバナに含まれている1-deoxynojirimycinと2,
5-dihydroxymethyl3,4-dihydroxypyrrolidine(DMD
P)によりα−グルコシダーゼの活性を阻害することが
でき、血糖の濃度の上昇を抑えるのに有効であり、しか
も天然の植物を用いることによって、人体に対して安全
なものであり、また、食事等で日常的に手軽に摂取また
は飲食して血糖の上昇を抑制することができるものであ
る。
As described above, the invention of claim 1 of the present invention is characterized in that at least one of communis and communis is used as a main component, and 1-deoxynojirimycin contained in communis and communis is used. And two,
5-dihydroxymethyl3,4-dihydroxypyrrolidine (DMD
P) can inhibit the activity of α-glucosidase, is effective in suppressing an increase in blood sugar concentration, and is safe for the human body by using a natural plant. It can be easily taken or eaten and consumed on a daily basis to suppress an increase in blood sugar.

【0062】また、本発明の請求項2の発明は、ツユク
サとオオボウシバナの少なくとも一方の粉砕物を主成分
とするので、ツユクサやオオボウシバナに含まれている
1-deoxynojirimycinと2,5-dihydroxymethyl3,4-dihydro
xypyrrolidine(DMDP)によりα−グルコシダーゼ
の活性を阻害することができ、血糖の濃度の上昇を抑え
るのに有効であり、しかも天然の植物を用いることによ
って、人体に対して安全なものであり、また、食事等で
日常的に手軽に摂取または飲食して血糖の上昇を抑制す
ることができるものであり、さらに、粉砕物にすること
により他の成分に添加する際に容易に分散混合すること
ができるものである。
In the invention of claim 2 of the present invention, since at least one of the pulverized product of the spiderwort and Oleander is used as a main component, it is included in the spiderweed and Oleander.
1-deoxynojirimycin and 2,5-dihydroxymethyl3,4-dihydro
xypyrrolidine (DMDP) can inhibit the activity of α-glucosidase, is effective in suppressing the increase in blood sugar concentration, and is safe for the human body by using natural plants. It can be easily ingested or eaten and consumed daily in meals and the like to suppress the rise of blood sugar, and can be easily dispersed and mixed when added to other components by being pulverized. You can do it.

【0063】また、本発明の請求項3の発明は、ツユク
サとオオボウシバナの少なくとも一方からの抽出物を主
成分とするので、ツユクサやオオボウシバナに含まれて
いる1-deoxynojirimycinと2,5-dihydroxymethyl3,4-dih
ydroxypyrrolidine(DMDP)によりα−グルコシダ
ーゼの活性を阻害することができ、血糖の濃度の上昇を
抑えるのに有効であり、しかも天然の植物を用いること
によって、人体に対して安全なものであり、また、食事
等で日常的に手軽に摂取または飲食して血糖の上昇を抑
制することができるものであり、さらに、抽出物にする
ことにより他の成分に添加する際に容易に分散混合する
ことができるものであり、しかも、抽出物にすることに
より上記の1-deoxynojirimycinと2,5-dihydroxymethyl
3,4-dihydroxypyrrolidine(DMDP)の濃度を高くす
ることができ、血糖上昇抑制の効果を向上させることが
できるものである。
Further, the invention of claim 3 of the present invention mainly comprises an extract from at least one of the spiderwort and Oleacea banana, so that 1-deoxynojirimycin and 2,5-dihydroxymethyl3, 4-dih
ydroxypyrrolidine (DMDP) can inhibit the activity of α-glucosidase, is effective in suppressing the increase in blood sugar concentration, and is safe for the human body by using natural plants. It can be easily ingested or eaten or consumed daily in a meal or the like to suppress a rise in blood sugar, and can be easily dispersed and mixed when added to other components by making it into an extract. It is possible to do so, and it is possible to extract 1-deoxynojirimycin and 2,5-dihydroxymethyl
It can increase the concentration of 3,4-dihydroxypyrrolidine (DMDP) and can improve the effect of suppressing a rise in blood glucose.

【図面の簡単な説明】[Brief description of the drawings]

【図1】α−グルコシダーゼ阻害活性試験のサンプルの
調製方法を示す説明図である。
FIG. 1 is an explanatory diagram showing a method for preparing a sample for an α-glucosidase inhibitory activity test.

【図2】DNS法を示す説明図である。FIG. 2 is an explanatory diagram showing a DNS method.

【図3】オオボウシバナから得られる熱水抽出物の水溶
性塩基性画分の成分1、2の調製方法を示す説明図であ
る。
FIG. 3 is an explanatory diagram showing a method for preparing components 1 and 2 of a water-soluble basic fraction of a hot water extract obtained from Pleurotus serrata.

【図4】オオボウシバナから得られる熱水抽出物の水溶
性塩基性画分の成分1に関する核磁気共鳴分析の結果を
示すグラフである。
FIG. 4 is a graph showing the result of a nuclear magnetic resonance analysis of component 1 of a water-soluble basic fraction of a hot water extract obtained from A. aureus.

【図5】オオボウシバナから得られる熱水抽出物の水溶
性塩基性画分の成分2に関する核磁気共鳴分析の結果を
示すグラフである。
FIG. 5 is a graph showing the result of nuclear magnetic resonance analysis of component 2 of a water-soluble basic fraction of a hot water extract obtained from A. americana.

【図6】HPLC用サンプルの調製方法を示す説明図で
ある。
FIG. 6 is an explanatory diagram showing a method for preparing a sample for HPLC.

【図7】LC/MSによる定量分析の結果を示すグラフ
である。
FIG. 7 is a graph showing the results of quantitative analysis by LC / MS.

【図8】ツユクサから得られる熱水抽出物の水溶性塩基
性画分の成分1、2の調製方法を示す説明図である。
FIG. 8 is an explanatory diagram showing a method for preparing components 1 and 2 of a water-soluble basic fraction of a hot water extract obtained from a spiderwort.

【図9】ツユクサから得られる熱水抽出物の水溶性塩基
性画分の成分1、2に関する核磁気共鳴分析の結果を示
すグラフである。
FIG. 9 is a graph showing the results of nuclear magnetic resonance analysis of components 1 and 2 of the water-soluble basic fraction of the hot water extract obtained from the spiderwort.

【図10】HPLC用サンプルの調製方法を示す説明図
である。
FIG. 10 is an explanatory view showing a method for preparing a sample for HPLC.

【図11】LC/MSによる定量分析の結果を示すグラ
フである。
FIG. 11 is a graph showing the results of quantitative analysis by LC / MS.

【図12】DMDP及びDNJ標準溶液による検量線を
示すグラフである。
FIG. 12 is a graph showing a calibration curve with DMDP and DNJ standard solutions.

【図13】実施例7の調製方法を示す説明図である。FIG. 13 is an explanatory view showing the preparation method of Example 7.

【図14】実施例及び比較例のスクロース負荷試験の結
果を示すグラフである。
FIG. 14 is a graph showing the results of a sucrose load test of Examples and Comparative Examples.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 芝野 真喜雄 大阪府高槻市奈佐原4丁目20番1号 大阪 薬科大学内 (72)発明者 竹内 一男 大阪府東大阪市菱屋西4丁目1番19号 株 式会社ヤマダ薬研内 Fターム(参考) 4B018 MD61 ME03 ME14 MF01 MF06 MF07 4C088 AB71 BA07 BA10 CA08 MA52 NA14 ZA70 ZC35  ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Makio Shibano 4-2-1-1, Nasawara, Takatsuki-shi, Osaka Prefecture Osaka Pharmaceutical University (72) Inventor Kazuo Takeuchi 4-1-1-19, Hishiya Nishi, Higashi-Osaka-shi, Osaka F-term in Yamada Yakken Co., Ltd. (reference) 4B018 MD61 ME03 ME14 MF01 MF06 MF07 4C088 AB71 BA07 BA10 CA08 MA52 NA14 ZA70 ZC35

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 ツユクサとオオボウシバナの少なくとも
一方を主成分として成ることを特徴とする機能性食品。
1. A functional food characterized by comprising at least one of communis and communis as a main component.
【請求項2】 ツユクサとオオボウシバナの少なくとも
一方の粉砕物を主成分として成ることを特徴とする機能
性食品。
2. A functional food comprising a ground material of at least one of communis and communis as a main component.
【請求項3】 ツユクサとオオボウシバナの少なくとも
一方からの抽出物を主成分として成ることを特徴とする
機能性食品。
3. A functional food comprising an extract from at least one of communis and communis as a main component.
JP2001118470A 2001-04-17 2001-04-17 Foods that suppress blood sugar rise Expired - Lifetime JP3581670B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001118470A JP3581670B2 (en) 2001-04-17 2001-04-17 Foods that suppress blood sugar rise

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001118470A JP3581670B2 (en) 2001-04-17 2001-04-17 Foods that suppress blood sugar rise

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003415363A Division JP3575766B2 (en) 2003-12-12 2003-12-12 Functional food

Publications (2)

Publication Number Publication Date
JP2002306123A true JP2002306123A (en) 2002-10-22
JP3581670B2 JP3581670B2 (en) 2004-10-27

Family

ID=18968854

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001118470A Expired - Lifetime JP3581670B2 (en) 2001-04-17 2001-04-17 Foods that suppress blood sugar rise

Country Status (1)

Country Link
JP (1) JP3581670B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007145751A (en) * 2005-11-28 2007-06-14 Maruzen Pharmaceut Co Ltd Anti-ageing agent, slimming agent, and humectant, and skin cosmetic
JP2008104399A (en) * 2006-10-25 2008-05-08 Spirulina Biological Lab Ltd Diabetes preventive food
KR101783309B1 (en) 2015-05-11 2017-10-10 대구가톨릭대학교산학협력단 A composition comprising extract of Tradescantia spathacea Sw. or compounds isolated therefrom for preventing or treating metabolic disorder

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007145751A (en) * 2005-11-28 2007-06-14 Maruzen Pharmaceut Co Ltd Anti-ageing agent, slimming agent, and humectant, and skin cosmetic
JP2008104399A (en) * 2006-10-25 2008-05-08 Spirulina Biological Lab Ltd Diabetes preventive food
KR101783309B1 (en) 2015-05-11 2017-10-10 대구가톨릭대학교산학협력단 A composition comprising extract of Tradescantia spathacea Sw. or compounds isolated therefrom for preventing or treating metabolic disorder

Also Published As

Publication number Publication date
JP3581670B2 (en) 2004-10-27

Similar Documents

Publication Publication Date Title
EA004148B1 (en) Pharmaceutical composition based on 3,6-anhydrogalactopyranose and/or derivatives thereof, and/or derivatives, and/or soluble saccharide containing the above compound, use of said composition and ingredients thereof, food product comprising said composition and use of said product
EP2251024A1 (en) Plant-origin drug for preventing or improving hyperuricemia
JP5274810B2 (en) AGEs production inhibitor
KR101209574B1 (en) Pharmaceutical compositions and health functional foods compositions for the improvement of liver functions containing compound isolated from Youngia denticulata as an active ingredient
KR20040107853A (en) Dendropanax morbifera Lev. extract having inhibitory effect of liver injury induced by ethanol
KR101616811B1 (en) Composition for treating diabete and diabete-induced complication containing an extract from Agrimonia pilosa
JP2007077117A (en) alpha-AMYLASE INHIBITOR
JP3581670B2 (en) Foods that suppress blood sugar rise
KR20060110968A (en) Novel lignan compounds, their preparation methods and their uses
KR101453455B1 (en) Pharmaceutical composition or healthy food composition containing Oenanthe javanica extract, fractions thereof or isolated flavonoidic compounds for antioxidant and antiobesity activity
JP2010270096A (en) Glucose absorption inhibitor
JP4344309B2 (en) Antihyperglycemic agent
JP3575766B2 (en) Functional food
KR100839185B1 (en) Composition comprising plantamajoside for treating or preventing diabete and diabetic complication
KR20040097112A (en) A health foodstuff having a effective component a Dendropanax morbifera Lev. extract, Dendropanax morbifera Lev. fractions
KR102146422B1 (en) Anti-cancer composition comprising extract of Vaccinium oldhamii
JP2002316935A (en) Hyperglycemia inhibitor
KR101153870B1 (en) Effective Perilla extract for inhibiting neuraminidase
KR101845704B1 (en) Composition comprising kynurenic acid for relieving hangover
KR20150037774A (en) Preparation of clove having enhanced antioxidative effect
KR101773348B1 (en) New compounds isolated from chestnut honey and antioxidant composition comprising the chestnut honey extract or fraction comprising the same
JP2000038347A (en) Tumor promotion inhibitor and food and drink
Dawood et al. The Antioxidant and DNA Protection Activity of the Tarragon’s Methanolic Extract
KR102222627B1 (en) Composition for preventing, improving or treating cancer comprising extract of Parthenocissus tricuspidata from Pinus densiflora as effective component
JP2005068081A (en) Prophylactic agent for carcinogenesis

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20031028

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20040106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040330

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040531

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040629

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040723

R150 Certificate of patent or registration of utility model

Ref document number: 3581670

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100730

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100730

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110730

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120730

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120730

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130730

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term